Hepion Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -4,458 | -8,503 | |
Net Income | -1,547 | -4,865 | -3,925 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,152 | -2,517 | -10,928 |
Cash | 406 | 1,497 | 2,115 |
Basic Shares | 139 | 6,718 | 5,799 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -67 | -67 | -77 | -86 |
EBITDA | -19,346 | -49,258 | -43,540 | -30,317 |
EBIT | -17,408 | -49,325 | -43,617 | -30,403 |
Net Income | -13,192 | -48,926 | -42,200 | -32,722 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -40,112 | |||
Free Cash Flow | -18,216 | -40,903 | -34,977 | -31,354 |
Cash | 406 | 14,785 | 51,189 | 91,348 |
Basic Shares | 122 | 3,970 | 3,811 | 3,514 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$11.11 |
2024-09-30 | -$0.72 |
2024-06-30 | -$0.67 |
2024-03-31 | -$2.42 |
